BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 28408460)

  • 1. Can histologic transformation of follicular lymphoma be predicted and prevented?
    Kridel R; Sehn LH; Gascoyne RD
    Blood; 2017 Jul; 130(3):258-266. PubMed ID: 28408460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transformation of follicular lymphoma.
    Lossos IS; Gascoyne RD
    Best Pract Res Clin Haematol; 2011 Jun; 24(2):147-63. PubMed ID: 21658615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transformation in follicular lymphoma: biology, prognosis, and therapeutic options.
    Wong E; Dickinson M
    Curr Oncol Rep; 2012 Oct; 14(5):424-32. PubMed ID: 22865028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic alterations reveal potential for higher grade transformation in follicular lymphoma and confirm parallel evolution of tumor cell clones.
    Eide MB; Liestøl K; Lingjaerde OC; Hystad ME; Kresse SH; Meza-Zepeda L; Myklebost O; Trøen G; Aamot HV; Holte H; Smeland EB; Delabie J
    Blood; 2010 Sep; 116(9):1489-97. PubMed ID: 20505157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Epstein-Barr virus in transformation of follicular lymphoma to diffuse large B-cell lymphoma: a case report and review of the literature.
    Granai M; Ambrosio MR; Akarca A; Mundo L; Vergoni F; Santi R; Mancini V; di Stefano G; Amato T; Bellan C; Puccini B; Sorrentino E; Naresh KN; Leoncini L; Marafioti T; Lazzi S
    Haematologica; 2019 Jun; 104(6):e269-e273. PubMed ID: 30846502
    [No Abstract]   [Full Text] [Related]  

  • 6. Genome-wide copy-number analyses reveal genomic abnormalities involved in transformation of follicular lymphoma.
    Bouska A; McKeithan TW; Deffenbacher KE; Lachel C; Wright GW; Iqbal J; Smith LM; Zhang W; Kucuk C; Rinaldi A; Bertoni F; Fitzgibbon J; Fu K; Weisenburger DD; Greiner TC; Dave BJ; Gascoyne RD; Rosenwald A; Ott G; Campo E; Rimsza LM; Delabie J; Jaffe ES; Braziel RM; Connors JM; Staudt LM; Chan WC
    Blood; 2014 Mar; 123(11):1681-90. PubMed ID: 24037725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral blood lymphocyte/monocyte ratio predicts outcome in follicular lymphoma and in diffuse large B-cell lymphoma patients in the rituximab era.
    Belotti A; Doni E; Bolis S; Rossini F; Casaroli I; Pezzatti S; Pogliani EM; Pioltelli PE
    Clin Lymphoma Myeloma Leuk; 2015 Apr; 15(4):208-13. PubMed ID: 25468321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic review of the potential of MicroRNAs in the management of patients with follicular lymphoma.
    Arzuaga-Mendez J; Lopez-Santillan M; Garcia-Ruiz JC; Lopez-Lopez E; Martin-Guerrero I
    Crit Rev Oncol Hematol; 2021 Mar; 159():103247. PubMed ID: 33515703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical impact of molecular features in diffuse large B-cell lymphoma and follicular lymphoma.
    Pon JR; Marra MA
    Blood; 2016 Jan; 127(2):181-6. PubMed ID: 26447189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Follicular lymphoma in young adults: a clinicopathological and molecular study of 200 patients.
    Duarte IX; Domeny-Duarte P; Wludarski SC; Natkunam Y; Bacchi CE
    Mod Pathol; 2013 Sep; 26(9):1183-96. PubMed ID: 23599146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting transformation in follicular lymphoma.
    de Jong D; de Boer JP
    Leuk Lymphoma; 2009 Sep; 50(9):1406-11. PubMed ID: 19606378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High TNFRSF14 and low BTLA are associated with poor prognosis in Follicular Lymphoma and in Diffuse Large B-cell Lymphoma transformation.
    Carreras J; Lopez-Guillermo A; Kikuti YY; Itoh J; Masashi M; Ikoma H; Tomita S; Hiraiwa S; Hamoudi R; Rosenwald A; Leich E; Martinez A; Roncador G; Villamor N; Colomo L; Perez P; Tsuji NM; Campo E; Nakamura N
    J Clin Exp Hematop; 2019; 59(1):1-16. PubMed ID: 30918139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of Patients With Histologic Transformation.
    Reddy NM
    Clin Lymphoma Myeloma Leuk; 2017 Jul; 17S():S100-S104. PubMed ID: 28760294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The role of translocations involving c-MYC/8q24, BCL2/18q21 and/or BCL6/3q27 genes in patients with follicular lymphoma. Retrospective analysis of single - centre data].
    Misyurina AE; Kravchenko SK; Kovrigina AM; Magomedova AU; Plastinina LV; Obukhova TN; Misyurin AV; Misyurin VA; Grebenuk LA; Babaeva FE; Baryakh EA; Vorobiev AI
    Ter Arkh; 2019 Jul; 91(7):52-62. PubMed ID: 32598736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unraveling transformation of follicular lymphoma to diffuse large B-cell lymphoma.
    González-Rincón J; Méndez M; Gómez S; García JF; Martín P; Bellas C; Pedrosa L; Rodríguez-Pinilla SM; Camacho FI; Quero C; Pérez-Callejo D; Rueda A; Llanos M; Gómez-Codina J; Piris MA; Montes-Moreno S; Bárcena C; Rodríguez-Abreu D; Menárguez J; de la Cruz-Merino L; Monsalvo S; Parejo C; Royuela A; Kwee I; Cascione L; Arribas A; Bertoni F; Mollejo M; Provencio M; Sánchez-Beato M
    PLoS One; 2019; 14(2):e0212813. PubMed ID: 30802265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transformed follicular lymphoma.
    Fischer T; Zing NPC; Chiattone CS; Federico M; Luminari S
    Ann Hematol; 2018 Jan; 97(1):17-29. PubMed ID: 29043381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Follicular lymphoma: 2020 update on diagnosis and management.
    Freedman A; Jacobsen E
    Am J Hematol; 2020 Mar; 95(3):316-327. PubMed ID: 31814159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Follicular lymphoma grade 3B and diffuse large B-cell lymphoma present a histopathological and molecular continuum lacking features of progression/ transformation.
    Koch K; Richter J; Hanel C; Huttmann A; Duhrsen U; Klapper W
    Haematologica; 2022 Sep; 107(9):2144-2153. PubMed ID: 35021600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of prior treatment on outcome of transformed follicular lymphoma and relapsed de novo diffuse large B cell lymphoma: a retrospective multicentre analysis.
    Lerch K; Meyer AH; Stroux A; Hirt C; Keller U; Viardot A; Marks R; Schreiber S; Pezzutto A; Scholz CW
    Ann Hematol; 2015 Jun; 94(6):981-8. PubMed ID: 25645656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The tumour microenvironment influences survival and time to transformation in follicular lymphoma in the rituximab era.
    Blaker YN; Spetalen S; Brodtkorb M; Lingjaerde OC; Beiske K; Østenstad B; Sander B; Wahlin BE; Melen CM; Myklebust JH; Holte H; Delabie J; Smeland EB
    Br J Haematol; 2016 Oct; 175(1):102-14. PubMed ID: 27341313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.